The healthtech sector’s spectacular surge in Spacs and de-Spacs
The Covid-19 pandemic triggered a significant rise in Spac investments in the healthtech sector. While Spacs offer opportunities for healthtech companies, the road to a de-Spac process can be complex and perilous.
Activist investors have had a quiet year, thanks to Covid-19. Even a group of investors renowned for their aggressive tactics were reluctant to publicly attack companies reeling from the impact of a global pandemic.
Increasing pressure on healthcare systems, massive tech growth and consumer-led demand are the perfect recipe for strong M&A activity in the emerging healthtech sector.
As technology continues to reshape large industrial companies, M&A activity in this sector is on the up. It brings with it a transformation of global workforces and a shift in national identities.
With growing pressure on businesses to incorporate ESG in dealmaking, green bonds are proving increasingly attractive. What does growth in this method of sustainable finance mean for the investment market?
With indicators pointing to the peak of the current financial cycle, an economic downturn could be imminent, bringing with it an uptick in distressed M&A activity.
M&A is tough. Megadeals can be even tougher. That’s exactly what Vicki Hollub, CEO of Houston-based Occidental Petroleum, discovered with last year’s $55bn takeover of US shale oil producer Anadarko Petroleum.
Several months into this global pandemic and businesses are facing a pivotal moment. Government reinforcement from bailouts and support schemes has been quick to land, but despite this injection of liquidity, the global economy will shrink by 5.2 per cent
FT Channels, a partnership destination that combines impactful and enriching multimedia content to spark curiosity and encourage discovery. Each vertical brings expert insights from the Financial Times and our Partners into the most pressing issues of our time.
FT Due Diligence is a video channel analysing the fast-moving world of M&A, illuminating the trends behind the complex global transactions and how to unlock value from acquisition deals. The channel alternates between independent reporting from FT journalists and insight on global dealmaking from law firm Baker McKenzie.